Home › Funds › AYAL Capital Advisors Ltd › BIO

AYAL Capital Advisors Ltd position in BIO

BIO RAD LABS INC CL A · Industrials

AYAL Capital Advisors Ltd reported holding 16,333 shares of BIO (BIO RAD LABS INC CL A) in its Q2 2026 13F filing — a position valued at US$4.8M, representing 1.33% of its reported portfolio and ranking #28 among its reported holdings. AYAL Capital Advisors Ltd has disclosed BIO holdings in 4 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)16.33K sh
Reported value held$4.80M
Portfolio Weight1.33%
First reportedQ4 2024
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How AYAL Capital Advisors Ltd's BIO position evolved

AYAL Capital Advisors Ltd first disclosed a stake in BIO in Q4 2024 at 13,600 shares (US$4.5M). The position peaked in Q4 2025 at 20,000 shares, worth US$6.1M. Across 4 filings, AYAL Capital Advisors Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 16,333 shares valued at US$4.8M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 13.60K $4.47M New
Q3 2025 17.50K $4.91M New
Q4 2025 20.00K $6.06M Add
Q2 2026 16.33K $4.80M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIO and 13F data

BIO (BIO RAD LABS INC CL A) is a Industrials company. 23 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$765.2M), ARIEL INVESTMENTS, LLC (US$239.8M), First Pacific Advisors, LP (US$118.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIO

All BIO fund holders →

FAQ

How long has AYAL Capital Advisors Ltd held BIO?

AYAL Capital Advisors Ltd has disclosed BIO holdings in 4 of the last 7 reported quarters, going back to Q4 2024.

What is AYAL Capital Advisors Ltd's current position in BIO?

As of Q2 2026, AYAL Capital Advisors Ltd holds 16.33K shares of BIO (BIO RAD LABS INC CL A), valued at $4.80M, representing 1.33% of its reported portfolio and ranking #28.

Has AYAL Capital Advisors Ltd been buying or selling BIO?

In the latest 13F filing (Q2 2026), AYAL Capital Advisors Ltd newly opened its position in BIO. The position peaked in Q4 2025 at 20.00K shares.

Which other funds hold BIO?

Other major institutional holders of BIO include First Eagle Investment Management, ARIEL INVESTMENTS, LLC, First Pacific Advisors, LP, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.